Search results
Results from the WOW.Com Content Network
The clinical development program for NV-5138 began with a Phase 1 trial initiated by Navitor Pharmaceuticals in 2018. [ 1 ] [ 7 ] This initial study was designed to evaluate the safety, tolerability, and pharmacokinetics of the compound in both healthy volunteers and patients diagnosed with TRD.
Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety , obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [ 1 ]
Mattingly has been involved with recent research and clinical trials regarding Spravato (esketamine) — a prescription nasal spray made by Johnson & Johnson (J&J) used to treat depression that ...
Esketamine, sold under the brand names Spravato (for depression) and Ketanest (for anesthesia) among others, [10] [12] is the S(+) enantiomer of ketamine. [5] [13] It is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression.
An official court date has been set for the trial of alleged “Ketamine Queen” Jasveen Sangha and Dr. Salvador Plasencia, who are accused of supplying Matthew Perry with the drugs that led to ...
A California doctor and a woman charged with illegally supplying the drug ketamine to "Friends" star Matthew Perry before his overdose death will face trial in March, according to court documents ...
Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, [2] [1] [3] employing approximately 5,400 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in ...
Dr. Salvador Plasencia and alleged drug dealer Jasveen Sangha, who prosecutors have also refer to as the “Ketamine Queen,” will be tried together. The trial is scheduled to begin on March 4, 2025.